HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie D Saba Selected Research

Drug Therapy (Chemotherapy)

1/2013S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase.
11/2011Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie D Saba Research Topics

Disease

10Neoplasms (Cancer)
02/2024 - 01/2004
9Inflammation (Inflammations)
07/2022 - 03/2006
6Carcinogenesis
01/2017 - 12/2009
4Colonic Neoplasms (Colon Cancer)
12/2014 - 11/2006
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2014
2Neuroblastoma
02/2024 - 10/2018
2Leukemia
02/2024 - 11/2011
2Lung Injury
01/2024 - 08/2011
2Infections
10/2023 - 04/2022
2Colitis-Associated Neoplasms
10/2015 - 01/2014
2Ischemia
01/2013 - 05/2011
2Adenoma (Adenomas)
09/2012 - 10/2006
1Nephrotic Syndrome (Syndrome, Nephrotic)
05/2023
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
07/2022
1Muscular Diseases (Myopathy)
07/2022
1Wounds and Injuries (Trauma)
09/2021
1Lymphopenia (Lymphocytopenia)
09/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2017
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2017
1Nephrosis
03/2017
1Ichthyosis (Xeroderma)
03/2017
1Colitis
10/2015
1Neoplastic Cell Transformation
12/2014
1Polyps
09/2012
1Hematologic Neoplasms (Hematological Malignancy)
11/2011
1Lymphoma (Lymphomas)
11/2011
1Acute Lung Injury
08/2011
1Edema (Dropsy)
08/2011
1Reperfusion Injury
05/2011
1Acute-Phase Reaction
03/2011
1Cardiovascular Diseases (Cardiovascular Disease)
07/2010
1Hypoxia (Hypoxemia)
06/2010
1Metabolic Diseases (Metabolic Disease)
04/2010
1Pathologic Neovascularization
03/2010
1Radiation Injuries (Radiation Sickness)
02/2010
1Autoimmune Diseases (Autoimmune Disease)
05/2007
1Lung Neoplasms (Lung Cancer)
12/2004
1Prostatic Neoplasms (Prostate Cancer)
12/2004

Drug/Important Bio-Agent (IBA)

16sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
09/2021 - 01/2004
11SphingolipidsIBA
09/2021 - 12/2004
8sphingosine 1-phosphate lyase (aldolase)IBA
05/2023 - 01/2004
6EnzymesIBA
10/2023 - 01/2010
5LipidsIBA
01/2017 - 01/2010
4LyasesIBA
03/2017 - 03/2011
3CytokinesIBA
12/2017 - 03/2011
3CeramidesIBA
11/2011 - 01/2004
2Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2018
2Sphingosine-1-Phosphate ReceptorsIBA
12/2014 - 03/2011
1Oncogene Proteins (Oncogene Protein)IBA
02/2024
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2024
11- (4- (1,2,3,4- tetrahydroxybutyl)- 1H- imidazol- 2- yl)ethanone oximeIBA
07/2022
1DystrophinIBA
07/2022
1Antiviral Agents (Antivirals)IBA
04/2022
1Interferon Type IIBA
04/2022
1VitaminsIBA
01/2020
1Vitamin B 6IBA
01/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2015
1NF-kappa B (NF-kB)IBA
10/2015
1MicroRNAs (MicroRNA)IBA
12/2014
1Sirolimus (Rapamycin)FDA Link
09/2012
1Okadaic AcidIBA
09/2012
1CateninsIBA
09/2012
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
09/2012
1calyculin AIBA
09/2012
1imidazoleIBA
08/2011
1Biomarkers (Surrogate Marker)IBA
02/2010
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2006
1SphingosineIBA
10/2006
1sphingosine kinaseIBA
10/2006
1Vitamin EFDA LinkGeneric
12/2004
1alpha-TocopherolFDA Link
12/2004
1gamma-TocopherolIBA
12/2004
1Immunologic Factors (Immunomodulators)IBA
01/2004

Therapy/Procedure

3Therapeutics
10/2018 - 06/2010
2Drug Therapy (Chemotherapy)
01/2013 - 11/2011
1Oral Administration
12/2014
1Chemoprevention
05/2007
1Transplantation
05/2007